Clinical Trial Update: COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA)

View source ↗

Summary

A clinical trial (NCT04881253) investigating retinal damage in COVID-19 patients using OCTA imaging has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy

Snippet

Sponsor: Centre Hospitalier Intercommunal Creteil | Conditions: Covid19, Retina Injury | Status: TERMINATED